More Americans die each year from antibiotic-resistant bacteria than AIDS, and there are no new drugs comingByTim FernholzPublishedNovember 7, 2013
Why is Big Pharma so interested in China? Just look at these scary diabetes numbersByAdam PasickPublishedSeptember 5, 2013
Changing the definition of “cancer” isn’t going to be a cure-allByEvan FleischerPublishedAugust 1, 2013
A new Indian-made vaccine is proving successful in tackling the second-biggest cause of death in childrenByJake Maxwell WattsPublishedMay 15, 2013
Ranbaxy settlement shows whistleblowing pays, but that’s probably not enough to make generic drugs saferByJake Maxwell WattsPublishedMay 14, 2013
The real reason Americans are missing out on life-saving drugsByLauren Alix BrownPublishedMay 9, 2013
Allow doctors to consult with drug companies to develop the medicines we need mostByDavid A. ShaywitzPublishedMay 7, 2013
Pfizer will now sell you Viagra directly to get around the counterfeitersByLeo MiraniPublishedMay 7, 2013
Pfizer’s disappointing performance could increase pressure to split the companyByGina ChonPublishedApril 30, 2013
Cancer drugs cost a lot, but a few more months with Mom is worth itByLauren Alix BrownPublishedApril 26, 2013
Novartis sued for paying pharmacist kick-backs to get patients on its drugsByTim FernholzPublishedApril 23, 2013
India’s $10 billion pipeline of generic cures will keep rolling—for nowByTim FernholzPublishedApril 1, 2013
Novartis wanted to pay an exec $78 million to keep secrets that don’t existByGwynn GuilfordPublishedFebruary 19, 2013
